Compare RYTM & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | FND |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.3B |
| IPO Year | 2017 | 2014 |
| Metric | RYTM | FND |
|---|---|---|
| Price | $82.62 | $50.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $131.14 | $73.44 |
| AVG Volume (30 Days) | 505.0K | ★ 2.7M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.34 | 1.05 |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $4,684,088,000.00 |
| Revenue This Year | $55.34 | $7.53 |
| Revenue Next Year | $86.06 | $7.68 |
| P/E Ratio | ★ N/A | $25.11 |
| Revenue Growth | N/A | ★ 5.12 |
| 52 Week Low | $55.31 | $46.47 |
| 52 Week High | $122.20 | $92.41 |
| Indicator | RYTM | FND |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 45.40 |
| Support Level | $74.50 | $46.47 |
| Resistance Level | $90.79 | $55.38 |
| Average True Range (ATR) | 3.24 | 2.70 |
| MACD | -0.28 | 0.03 |
| Stochastic Oscillator | 23.60 | 39.37 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.